ArticleJournal of clinical medicine2021

Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3): A Novel Marker for Lymphoma Development among Patients with Young Onset Sjogren's Syndrome.

Evangelia Argyriou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.